Budesonide add-on therapy improves markers of disease activity but fails to improve histology
The addition of budesonide is associated with clinically meaningful improvements in biochemical markers of disease activity but no improvement in liver histology in high-risk patients with primary biliary cholangitis (PBC) ...
Apr 13, 2018
0
1